GANX
Price
$1.69
Change
+$0.01 (+0.60%)
Updated
Jul 25 closing price
Capitalization
58.43M
11 days until earnings call
IPA
Price
$2.16
Change
-$0.15 (-6.49%)
Updated
Jul 25 closing price
Capitalization
98.85M
Interact to see
Advertisement

GANX vs IPA

Header iconGANX vs IPA Comparison
Open Charts GANX vs IPABanner chart's image
Gain Therapeutics
Price$1.69
Change+$0.01 (+0.60%)
Volume$63.73K
Capitalization58.43M
ImmunoPrecise Antibodies
Price$2.16
Change-$0.15 (-6.49%)
Volume$2.02M
Capitalization98.85M
GANX vs IPA Comparison Chart in %
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. IPA commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a StrongBuy and IPA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (GANX: $1.69 vs. IPA: $2.16)
Brand notoriety: GANX and IPA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 23% vs. IPA: 64%
Market capitalization -- GANX: $58.43M vs. IPA: $98.85M
GANX [@Biotechnology] is valued at $58.43M. IPA’s [@Biotechnology] market capitalization is $98.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileIPA’s FA Score has 0 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • IPA’s FA Score: 0 green, 5 red.
According to our system of comparison, IPA is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 4 TA indicator(s) are bullish while IPA’s TA Score has 4 bullish TA indicator(s).

  • GANX’s TA Score: 4 bullish, 5 bearish.
  • IPA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IPA is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а +6.62% price change this week, while IPA (@Biotechnology) price change was +24.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

GANX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPA($98.9M) has a higher market cap than GANX($58.4M). IPA YTD gains are higher at: 424.654 vs. GANX (-21.759). GANX has higher annual earnings (EBITDA): -20.26M vs. IPA (-45.11M). IPA has more cash in the bank: 12.9M vs. GANX (9.07M). GANX has less debt than IPA: GANX (607K) vs IPA (12.9M). IPA has higher revenues than GANX: IPA (24M) vs GANX (0).
GANXIPAGANX / IPA
Capitalization58.4M98.9M59%
EBITDA-20.26M-45.11M45%
Gain YTD-21.759424.654-5%
P/E RatioN/AN/A-
Revenue024M-
Total Cash9.07M12.9M70%
Total Debt607K12.9M5%
FUNDAMENTALS RATINGS
IPA: Fundamental Ratings
IPA
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXIPA
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMTEF6.38N/A
N/A
Smart Eye
TRPRF15.50N/A
N/A
TC Energy Corp.
AETUF19.60-0.35
-1.74%
Arc Resources Ltd.
WIPKF29.42-3.52
-10.67%
Winpak Ltd.
EBZT0.43-0.06
-12.37%
EVERYTHING BLOCKCHAIN INC.

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+0.60%
COYA - GANX
34%
Loosely correlated
-0.74%
OCUL - GANX
32%
Poorly correlated
+2.43%
KRRO - GANX
32%
Poorly correlated
+0.69%
MGTX - GANX
31%
Poorly correlated
+0.72%
TPST - GANX
31%
Poorly correlated
+20.59%
More

IPA and

Correlation & Price change

A.I.dvisor tells us that IPA and VANI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPA and VANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPA
1D Price
Change %
IPA100%
-6.49%
VANI - IPA
29%
Poorly correlated
+0.62%
TPST - IPA
25%
Poorly correlated
+20.59%
NNVC - IPA
24%
Poorly correlated
-1.75%
GANX - IPA
23%
Poorly correlated
+0.60%
ABCL - IPA
22%
Poorly correlated
+1.79%
More